Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has obtained the Food and Drug Administration’s clearance for amphotericin B liposome for injection, 50 mg /vial, which is a generic of ...

A single infusion of liposomal amphotericin B was not inferior to a 15-dose regimen of amphotericin B deoxycholate. Despite impressive cure rates for several antileishmanial agents, lengthy treatment ...

Walsh et al. [14] studied 556 patients who were intolerant of or refractory to conventional amphotericin B therapy and were then switched to amphotericin B colloidal dispersion. Renal dysfunction ...

Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related death in sub-Saharan Africa. Whether a treatment regimen that includes a single high dose of liposomal ...

Amphotericin B vs itraconazole for HIV-associated talaromycosis Treatment with amphotericin B was superior to itraconazole as an induction therapy for HIV-associated talaromycosis. Treatment with the ...

SAN FRANCISCO, CA—The increased use of liposomal amphotericin B (L-AMB) in neonates has occurred without evidence of increased efficacy or safety, presented Siyun Liao, PharmD, from the University of ...

Topical antifungals are generally and extensively used in the management of superficial fungal infections in both adults and children. However, systemic antifungals began to be used with the ...

Treatment of cryptococcal meningitis typically includes 1 week of intravenous therapy with amphotericin B deoxycholate. However, this treatment carries a substantial risk of toxic effects, and the ...